Showing results (191-200 of 360) with videos related to

Sort By:
Pageof 36
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2004
Ethanol causes inflammation in the airways by a neurogenic and TRPV1-dependent mechanismMarcello Trevisani, David Gazzieri, Francesca Benvenuti, et al.
Fitoterapia|June 6, 2022
Local effects of natural alkylamides from Acmella oleracea and synthetic isobutylalkyl amide on neuropathic and postoperative pain models in miceJorge Luiz Dallazen, Bruna Barbosa da Luz, Daniele Maria-Ferreira, et al.
Cephalalgia : an International Journal of Headache|May 15, 2018
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare NetworkChiara Lupi, Luana Evangelista, Valentina Favoni, et al.
Eating and Weight Disorders : EWD|February 18, 2022
Bridging cognitive, phenomenological and psychodynamic approaches to eating disordersGiovanni Castellini, Emanuele Cassioli, Eleonora Rossi, et al.
Eating and Weight Disorders : EWD|April 14, 2021
Orthorexia among patients with eating disorders, student dietitians and general population: a pilot studyDaniele Busatta, Emanuele Cassioli, Eleonora Rossi, et al.
Iscience|December 2, 2022
Resolving tricky nodes in the tree of life through amino acid recodingMattia Giacomelli, Maria Eleonora Rossi, Jesus Lozano-Fernandez, et al.
The Science of the Total Environment|October 30, 2024
Improving the waste management system in an Italian footwear district applying MFA and LCAEleonora Rossi, Francesco Arfelli, Luca Barani, et al.
Brain, Behavior, and Immunity|March 20, 2023
Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in miceLorenzo Landini, Matilde Marini, Daniel Souza Monteiro de Araujo, et al.
The Journal of Clinical Investigation|September 6, 2019
Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in miceFrancesco De Logu, Simone Li Puma, Lorenzo Landini, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2004
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potentialGiovanni Appendino, Luciano De Petrocellis, Marcello Trevisani, et al.
Pageof 36